Rating History for Impax Laboratories (IPXL) by Goldman Sachs
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/28/2017 | N/A | New Coverage | Neutral (N/A) |
20.00 (N/A) |
22.90 (18.30) |
-20.09% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/28/2017 | N/A | New Coverage | Neutral (N/A) |
20.00 (N/A) |
22.90 (18.30) |
-20.09% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||